Capping of eucaryotic mRNAs

TL;DR: Over the last 20 or so years, the study of amino acid sequences of proteins derived from different biologic species has greatly enriched the authors' knowledge of both the mechanisms of molecular evolution and the phylogenetic relationships of the species.

TL;DR: There was no significant difference in sensitivity to hypertonic block of in vivo translation of influenza viral m RNAs and vesicular stomatitis virus mRNAs, the latter of which possess a virus‐directed structure at the 5′‐terminus.

TL;DR: A preeminent feature of eukaryotic messenger RNAs is the presence of a peculiar structure of methylated nucleotides “capping” the 5′ end of the molecule, but why should internal sequences be forbidden in messengers that have bypassed the need of a 5′-terminal cap?

TL;DR: The genetic information carried by eukaryotic messenger RNAs can be translated to polypeptides either in cell-free protein synthesizing systems or after microinjection into living cells.

TL;DR: Messenger RNAs from mouse myeloma cells contain N6-methyl adenosine and novel 5′ termini having 7-methylguanosine in a 5′, 5′triphosphate linkage with ribose-methylated nucleosides, suggesting a general feature of mRN A in eukaryotes.

TL;DR: A comparison of the rates of adoption and adoption of different approaches to translation of EUKARYOTIC mRNAs in the US and Europe over the past 50 years reveals a clear trend towards adoption of a more holistic approach.

TL;DR: This research attacked the prokaryote-prokaryotes “ cellular “spatially aggregating” mechanism with a “knock-on” effect that results in knock-on effects that affect the ability of these cells to “talk” to each other.

TL;DR: Under denaturing conditions of sodium dodecyl sulfate-polyacrylamide gel electrophoresis two majorpolypeptides were detected in purified enzyme preparations and suggested they were polypeptide components of the 127,000 molecular weight enzyme system.